DRUG FOR CORONAVIRUS
His grandfather died of pancreatic cancer: This Hyderabad startup founder is using AI to develop a personalised cancer vaccines
Hyderabad-based biotech startup PopVax, founded by Soham Sankaran, is developing AI-powered personalised cancer vaccines using mRNA technology. Inspired partly by his family's experience with pancreatic cancer, he aims to help the immune system identify and attack cancer cells using treatments designed around individual patients' tumour genetics.
Nobel 2026: Ozempic, Mounjaro research tipped for medicine prize
The 2026 Nobel season is set to reveal the winners of various prestigious awards, starting with medicine. The medicine prize is anticipated to acknowledge research on appetite-regulating hormones related to weight-loss drugs. Alongside this, other fields such as skin regeneration and immunology are also potential candidates for recognition. The peace prize is expected to generate significant interest due to last year's controversial winner.
COVID-19 had a scientific head start; the next pandemic virus may be a stranger. NVIDIA and Google DeepMind are using AI to map 2,800 viruses before the next outbreak
An international collaboration has developed a dataset of predicted protein structures from more than 2,800 viruses. This data is accessible through the AlphaFold Database, aiding in pandemic preparedness. Researchers can accelerate their investigations of new viruses using this information for potential treatments. The dataset provides insights into protein interactions, making it a valuable resource for global scientists.
Tech Mahindra expects to begin trials for planned COVID drug in 3-4 months
The company along with Reagene Biosciences has filed for the patent for a molecule that can be used to develop a drug against coronavirus. Makers Lab started the computational modelling analysis of the coronavirus. Based on computational docking and modelling studies, Makers Lab and its partner decided to develop a single molecule from a list of 8,000 USFDA-approved molecules.
Scientists find new drug target to treat coronavirus, fight future pandemic
The latest study, published in the journal Science Signaling, provides critical information that could aid drug development against future coronaviruses as well as SARS-CoV-2.
Tech Mahindra, Reagene to file patent for molecule that potentially attacks coronavirus
Tech Mahindra Global Head (Makers Lab) Nikhil Malhotra told that the company along with its partner is applying for patenting on which further testing will be done. Markers Lab is the research and development arm of Tech Mahindra.
- Go To Page 1

Remdesivir no life-saving drug in COVID-19: Maharashtra task force
"It only arrests the replication of the virus and therefore reduces the hospital stay and convalescence of the patient by one-two days. This leads to a reduction inthe hospital stay by two days at the most. It is possible to save patients even without Remedesivir," the task force said in the advisory.

Russia to supply Avifavir drug to 17 nations for coronavirus treatment
Avifavir will be delivered to Argentina, Bulgaria, Brazil, Chile, Colombia, Ecuador, El Salvador, Honduras, Kuwait, Panama, Paraguay, Saudi Arabia, Serbia, Slovakia,South Africa, UAE and Uruguay. The drug has already been delivered to Belarus, Bolivia, Kazakhstan, Kyrgyzstan, Turkmenistan and Uzbekistan.

Russian produced anti-covid drug ready for exports
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar Group produced the first 100,000 courses of the Russian coronavirus drug Avifavir in June, significantly exceeding initially planned production levels of 60,000 courses.

COVID-19: CSIR institute to conduct clinical trials of antiviral drug Umifenovir
The drug has a good safety profile and acts by preventing entry of viruses into human cells and also by priming the immune system, according to a statement.

Russian hospitals start receiving indigenously made anti-Covid drugs; mass production launched
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and the ChemRar Group on Thursday announced the delivery of the first batch of Avifavir to Russian hospitals. Avifavir is one of the two registered COVID-19 drugs in the world.

Raghava Life Sciences in talks with formulators for potential Covid drug Favipiravir
Favipiravir, a generic version of Avigan that is used to treat influenza in Japan, is being studied as an experimental drug in treating the novel Coronavirus disease in India, Russia, China, Japan, Turkey, Thailand and others.

Hydroxychloroquine-azithromycin combo may be potentially lethal: Study
Hydroxychloroquine and azithromycin, alone or in combination, have been proposed for treatment of COVID-19 patients, the researchers said. They explained that reports of potentially lethal acute cardiac proarrhythmogenic effects -- promoting irregular heart rhythms -- have been described mainly with azithromycin but also with hydroxychloroquine.

Indian-origin scientist identifies four possible drugs to treat COVID-19
The study, published in the journal Pathogens, found that all four drugs were effective in inhibiting, or blocking, the coronavirus' RNA proteins from making genomic copies of the novel coronavirus.

Company says drug proved effective against virus in US study
Gilead Sciences's remdesivir would be the first treatment to pass such a test against the virus, which has killed more than 218,000 people since it emerged late last year in China.

India sending hydroxychloroquine to 55 coronavirus-hit countries
Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19 and it is being tested on more than 1,500 coronavirus patients in New York.

India to boost drug ingredient output to pare China reliance
India plans to ramp up production of pharmaceutical ingredients to become an alternative supplier to China.

Malaria medicine 'Hydroxychloroquine' being administered to 1,100 COVID19 patients in New York: US President Donald Trump
An inexpensive drug widely used since 1955 to treat malaria, Hydroxychloroquine is considered to have relatively harmless side effects. It is being tested out on the COVID-19 patients in New York on an experimental basis, hoping that this will give a solution in the treatment against the novel coronavirus.

Novartis CEO says Malaria drug is biggest hope against coronavirus - SonntagsZeitung
Other companies including Bayer and Teva have also agreed to donate hydroxychloroquine or similar drugs, while Gilead Sciences is testing its experimental drug remdesivir against coronavirus.

'Nearly 70 drugs that may be effective against COVID-19 identified'
According to researchers, some of the drugs are already used to treat diseases such as diabetes & hypertension.

Kerala: British national given HIV antiretroviral drugs to treat coronavirus now tests negative
A British national, who was administered HIV antiretroviral drugs for treating his coronavirus infection, has tested negative, doctors at the Ernakulam Medical College Hospital here said on Wednesday

US President touts anti-malarial drug as potential treatment for coronavirus
As the number of coronavirus cases in the US continued to rise, President Donald Trump on Thursday said that hydroxychloroquine, an anti-malarial drug, can potentially be effective for treating coronavirus.

Covid-19: Export curbs on imported API drugs under review
The commerce and industry ministry is studying a proposal to allow exports of drugs from active pharmaceutical ingredients (API) which have been imported under an advance license wherein duty-free imports are bound to certain export obligations.

Combination of two anti-HIV drugs proved crucial in Coronavirus treatment, Rajasthan official
Additional Chief Secretary (Medical and Health) Rohit Kumar Singh said the patients' condition improved after they were administered the anti-HIV drugs. Three of the four patients in the state have now been declared coronavirus-free. Singh said the first two patients tested positive for the virus were an Italian couple.

No shortage of APIs and formulations in the country: Govt
NPPA has informed that it has not received any reference from pharma associations regarding steep increase in price of medicines due to outbreak of COVID-19 (coronavirus) in China. "NPPA is monitoring the situation regularly to ensure that ceiling prices of essential medicines are not breached," Minister for Chemicals & Fertilizers DV Sadananda Gowda said in a reply.

Covid-19: China stalls supplies, India faces anti-retroviral shortage
Antiretrovirals - used for treating coronavirus - are manufactured by around five major pharma companies in India. The demand for such drugs have surged, and China is holding back supplies to meet its own demand. Manufacturers said they presently have stocks to treat around one lakh patients only. China is the only supplier of these APIs to India and there is no alternative source.

Coronavirus medicine: An arthritis drug could be the answer everyone is looking for
The Chinese government approved Swiss drugmaker Roche's anti-inflammation drug Actemra to treat severe coronavirus symptoms. This comes at a time when countries around the world desperately search for new ways to combat the deadly infection.

Sun Pharma flags hypertension drug shortage
Indian companies are the main supplier of generic drugs to the world and procure almost 70% of the active pharmaceutical ingredients (APIs) for their medicines from China. The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies and industry experts expect Indian generic drugmakers to face supply shortages from China if epidemic drags on.

Sun Pharma flags hypertension drug shortage due to supply constraint
The company said it does not source the active pharmaceutical ingredients (API) of the drug from China, adding that supply of some other APIs was impacted by the coronavirus.
Load More